NYSE · BLCO
Bausch + Lomb Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for BLCO has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $0.35 | $0.38 | $0.28 | 5 |
| Mar 2027 | $0.12 | $0.12 | $0.11 | 2 |
| Jun 2027 | $0.24 | $0.25 | $0.23 | 2 |
| Sep 2027 | $0.23 | $0.26 | $0.21 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
BNK Invest · Fintel · MarketBeat · The Motley Fool- BNK Invest · Oct 29, 6:44 AM EDTBLCO Crosses Above Average Analyst TargetIn recent trading, shares of Bausch + Lomb Corporation (Symbol: BLCO) have crossed above the average analyst 12-month target price of $19.47, changing hands for $20.40/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgra
- Fintel · Oct 29, 4:58 AM EDTBausch + Lomb Corporation Director Nathalie Bernier Resigns on October 28, 2026On October 28, 2026, Nathalie Bernier notified Bausch + Lomb Corporation of her decision to resign from the Board of Directors of the Company and from the Science and Technology Committee of the Board, effective at the close of business.In connection with Ms. Bernier’s resi
- MarketBeat · Oct 29, 2:04 AM EDTWhat Bausch + Lomb (BLCO) Said on Its Q3 Earnings CallBausch Health: A Buyout Bid Could Be the Ticket to Unlock ValueBausch + Lomb (NYSE:BLCO) reported third-quarter revenue growth across all three business segments, raised its full-year outlook for the third time in 2026 and highlighted continued margin expansion and cash generatio
- Fintel · Oct 28, 11:43 AM EDTBausch + Lomb Reports Third-Quarter 2026 Revenue of $1.375 Billion and Raises Full-Year GuidanceBausch + Lomb Corporation reported total revenue of $1.375 Billion for the third quarter of 2026, as compared to $1.281 billion in the third quarter of 2025, an increase of 7%. Excluding the unfavorable impact of foreign exchange of $6 million, revenue increased by approximately
- The Motley Fool · Oct 28, 9:58 AM EDTBausch + Lomb (BLCO) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Oct 28, 8:23 AM EDTBausch + Lomb Swings To Profit In Q3, Lifts FY26 Guidance; Pre-market Shares Up(RTTNews) – Bausch + Lomb Corp. (BLCO), a global eye health company, on Wednesday announced a return to profit for the third quarter of fiscal 2026, as revenue increased across all three business segments. The company also raised its full-year revenue and adjusted EBITDA guidance
- Zacks · Oct 28, 7:35 AM EDTBausch + Lomb (BLCO) Surpasses Q3 Earnings and Revenue EstimatesBausch + Lomb (BLCO) delivered earnings and revenue surprises of +61.91% and +0.14%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Sep 18, 10:44 AM EDTWeekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead(RTTNews) – Biotech investors tracked a busy week marked by regulatory approvals, strategic collaborations, workforce restructuring and key clinical trial readouts.
- Zacks · Sep 14, 11:14 AM EDTBLCO Gains European CE Mark for Next-Gen SeeLyra Femtosecond LaserBausch + Lomb gains European CE Mark approval for SeeLyra, expanding its surgical portfolio with a compact laser platform for cataract and corneal procedures.
- RTTNews · Sep 11, 7:06 AM EDTBausch + Lomb Gains CE Mark For SeeLyra Femtosecond Laser(RTTNews) – Bausch + Lomb Corporation (BLCO) announced that the European Union has granted CE Mark approval for SeeLyra, its next-generation femtosecond laser platform.
- RTTNews · Sep 11, 6:24 AM EDTBausch + Lomb Announces European CE Mark Approval Of SeeLyra; To Seek Approvals Around The World(RTTNews) – Bausch + Lomb (BLCO) announced European CE Mark approval of SeeLyra, the company's next generation femtosecond laser. SeeLyra will be available in Europe on a limited basis in the coming months, with increasing availability expected in 2027. Bausch + Lomb is also in t
- Zacks · Aug 25, 11:53 AM EDTBausch + Lomb Advances Two First-in-Class Eye Health TherapiesBLCO advances two eye-health candidates after positive trial results, with combined estimated peak sales exceeding $2 billion.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Bausch + Lomb Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.